It's higher in the Asia-Pacific region, because of a greater prevalence of hepatitis B hepatitis C infection which causes the number of liver cancer incidence to rise.
Nexavar is seen as a drug with great potential because it is often compared to the blockbuster drug Avastin, manufactured by biotechnology giant Genentech. Both drugs target a tumor cell's ability to grow by cutting off its blood supply. One potential advantage Nexavar has over Avastin, is that it's taken orally versus intravenously at a medical clinc.
Last year the Nexavar was given "fast track" status, which allows the approval process to be sped up.
This designation is given to drugs that treat serious or life-threatening diseases where there is an unmet medical need. Liver cancer is the fifth most common cancer in the world, and is the most prevalent in developing countries.read more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment